e-Article
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials
Document Type
Journal
Author
Orkin, Chloe; DeJesus, Edwin; Sax, Paul E.; Arribas, Jose R.; Gupta, Samir K.; Martorell, Claudia; Stephens, Jeffrey L.; Stellbrink, Hans-Jurgen; Wohl, David; Maggiolo, Franco; Thompson, Melanie A.; Podzamczer, Daniel; Hagins, Debbie; Flamm, Jason A.; Brinson, Cynthia; Clarke, Amanda; Huang, Hailin; Acosta, Rima; Brainard, Diana M.; Collins, Sean E.; Martin, Hal; GS-US-380-1489 Study Investigator; GS-US-380-1490 Study Investigator
Source
Subject
Language
English
ISSN
23523018